company background image
C2C logo

Concord Medical Services Holdings DB:C2C Stock Report

Last Price

€6.25

Market Cap

€30.8m

7D

0%

1Y

-38.7%

Updated

26 Oct, 2024

Data

Company Financials

Concord Medical Services Holdings Limited

DB:C2C Stock Report

Market Cap: €30.8m

C2C Stock Overview

Through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. More details

C2C fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Concord Medical Services Holdings Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Concord Medical Services Holdings
Historical stock prices
Current Share PriceUS$6.25
52 Week HighUS$36.00
52 Week LowUS$3.26
Beta-0.25
1 Month Change0%
3 Month Change-1.57%
1 Year Change-38.73%
3 Year Change-71.85%
5 Year Change-73.74%
Change since IPO-89.50%

Recent News & Updates

Recent updates

Shareholder Returns

C2CDE HealthcareDE Market
7D0%-0.3%-0.2%
1Y-38.7%16.5%7.0%

Return vs Industry: C2C underperformed the German Healthcare industry which returned 32.1% over the past year.

Return vs Market: C2C underperformed the German Market which returned 19.6% over the past year.

Price Volatility

Is C2C's price volatile compared to industry and market?
C2C volatility
C2C Average Weekly Movementn/a
Healthcare Industry Average Movement4.8%
Market Average Movement4.9%
10% most volatile stocks in DE Market11.7%
10% least volatile stocks in DE Market2.4%

Stable Share Price: C2C's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine C2C's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1997727Jianyu Yangwww.concordmedical.com

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. It operates in two segments, Network and Hospital. The company’s services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.

Concord Medical Services Holdings Limited Fundamentals Summary

How do Concord Medical Services Holdings's earnings and revenue compare to its market cap?
C2C fundamental statistics
Market cap€30.81m
Earnings (TTM)-€49.30m
Revenue (TTM)€61.37m

0.5x

P/S Ratio

-0.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
C2C income statement (TTM)
RevenueCN¥471.70m
Cost of RevenueCN¥552.48m
Gross Profit-CN¥80.78m
Other ExpensesCN¥298.15m
Earnings-CN¥378.93m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-87.28
Gross Margin-17.13%
Net Profit Margin-80.33%
Debt/Equity Ratio175.4%

How did C2C perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/10/26 03:08
End of Day Share Price 2024/07/29 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Concord Medical Services Holdings Limited is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ye YinBrean Capital
Jessica LiChina International Capital Corporation Limited
Michael WuJMP Securities